ClinicalTrialsFinder
CompletedPhase 3ACTRN12611000918921

Efficacy of Triple Antibiotic Therapy in Symptomatic Blastocystis patients

In patients with symptomatic Blastocystis, is triple antibiotic therapy effective in clearing Blastocystis from the stool and improving clinical well-being?

Sponsor

University of Queensland

Enrollment

10 participants

Start Date

Aug 9, 2011

Study Type

Interventional

Conditions

Blastocystis infection

Summary

We intend to evaluate the efficacy of 14 days of the triple antibiotics listed above in eradicating Blastocystis infection in symptomatic patients.

Eligibility

Sex: Both males and femalesMin Age: 18 YearssMax Age: 70 Yearss

Plain Language Summary

Simplified for easier understanding

This trial evaluates whether a combination of three antibiotics can effectively treat symptoms caused by Blastocystis, a common intestinal parasite. Adults aged 18-70 with gastrointestinal symptoms where Blastocystis is the only identified cause are eligible. People with sulphur allergies or who are pregnant cannot participate.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Administration of 14 days of oral capsule antibiotics: specifically trimethoprim/sulfamethoxazole 160/800mg twice daily, diloxanide furoate 500 mg three times daily and secnidazole 400mg three times d

Administration of 14 days of oral capsule antibiotics: specifically trimethoprim/sulfamethoxazole 160/800mg twice daily, diloxanide furoate 500 mg three times daily and secnidazole 400mg three times daily

Locations(1)

QLD, Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12611000918921